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Abstract Dark neurons have plagued the interpretation of
brain tissue sections, experimentally and clinically. Seen
only when perturbed but living tissue is Wxed in aldehydes,
their mechanism of production is unknown. Since dark neu-
rons are seen in cortical biopsies, experimental ischemia,
hypoglycemia, and epilepsy, we surmised that glutamate
release and neuronal transmembrane ion Xuxes could be the
perturbation leading to dark neuron formation while the
Wxation process is underway. Accordingly, we excised
biopsies of rat cortex to simulate neurosurgical production
of dark neurons. To ascertain the role of glutamate, block-
ade of N-methyl-D-aspartate (NMDA) and non-NMDA
receptors was done prior to formaldehyde Wxation. To
assess the role of transmembrane sodium ion (and implic-
itly, water) Xuxes, tetraethylammonium (TEA) was used.
Blockade of NMDA receptors with MK-801 and non-
NMDA receptors with the quinoxalinediones (CNQX and
NBQX) abolished dark neuron formation. More delayed
exposure of the tissue to the antagonist, CNQX, by admix-
ing it with the Wxative directly, allowed for some produc-
tion of dark neurons. Aminophosphonoheptanoate (APH),
perhaps due to its polarity, and TEA, did not prevent dark
neurons, which were abundant in control formaldehyde
Wxed material unexposed to either receptor or ion channel
antagonists. The results demonstrate a role for the pharma-
cologic subtypes of glutamate receptors in the pathogenetic
mechanism of dark neuron formation. Our results are con-
sistent with the appearance of dark neurons in biopsy where
the cerebral cortex has been undercut, and rendered locally
ischemic and hypoglycemic, as well as in epilepsy, hypo-
glycemia, and ischemia, all of which lead to glutamate
release. Rather than a pressure-derived mechanical origin,
we suggest that depolarization, glutamate release or recep-
tor activation are more likely mechanisms of dark neuron
production.
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Introduction
For almost a century, dark neurons have plagued the inter-
pretation of brain sections in both experimental and clinical
material [3]. Dark neurons were Wrst noticed to occur in
neurosurgical biopsies, but were not seen at autopsy.
Because of their appearance after delayed Wxation or after
mechanical trauma [23] to the brain prior to Wxation, a
mechanical stress force [3] was hypothesized to produce
dark neurons [4]. This explanation may appear cogent,
since it is in accord with the appearance of dark neurons in
neurosurgically obtained brain tissue, where biopsies are
always subjected to mechanical forces prior to Wxation.
However, dark neurons also appear under conditions
where no trauma or mechanical forces are applied to the
brain. For example, inhibition of the Na+–K+ ATPase pump
with ouabain causes dark neurons [6]. Also, epilepsy pro-
duces widespread dark neurons throughout the brain, even
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gives rise to dark neurons acutely, which can go on to
recover over several hours, indicating the reversibility of
dark neuron formation. Lastly, ischemia acutely gives rise
to dark neurons [7, 17, 19].
All these conditions either run down neuronal ion
gradients (ouabain), release excessive neurotransmitter
(epilepsy), release excitatory aspartate (hypoglycemia), or
release glutamate (ischemia). Hence, we hypothesized a
pharmacologic, and not a pressure-derived mechanical ori-
gin of dark neurons. We chose receptor antagonists for the
various types of glutamate receptor subtypes [5] to study
the role of these receptors in the production of dark neu-
rons, and blocked Na+ channels to study the role of sodium
and accompanying passive water movement across the
cell membrane in the genesis of dark neurons. The results
suggest that dark neurons can be prevented using various
pharmacologic forms of glutamate antagonism.
Materials and methods
Male Wistar rats (n = 42) weighing 250–300 g were anes-
thetized with 2% halothane administered by a nose cone,
which allowed spontaneous ventilation. A scalp incision
was made and the skull was exposed. A dental drill was
used to excise a circular portion of skull, thereby exposing
the cortex. To simulate a neurosurgical cortical biopsy,
2 £ 1 £ 1 mm (2 mm3) portions of tissue were excised
(n = 126, three per rat) with a scalpel. These tissue biopsies
were then either treated with various antagonists or were
left untreated prior to aldehyde Wxation.
The biopsies were randomly divided into seven groups.
Six of the seven aliquots of cortex were exposed to the
pharmacologic antagonists for 3 h prior to Wxation, with
two of these groups also undergoing concurrent Wxation
with antagonist and formaldehyde. The seventh was Wxed
in formaldehyde, without antagonism, as a positive control
for the production of dark neurons. To determine the poten-
tial of glutamate receptor blockade and sodium channel
blockade in preventing dark neurons, the six treated groups
were exposed to the various antagonists. The seventh ali-
quot of cortical tissue was immersed in 4% formaldehyde
Wxative. All antagonists and the Wxative were phosphate-
buVered (0.2 M disodium hydrogen phosphate) to pH 7.35,
and the tissue was exposed to all antagonists for 3 h, prior
to Wxation. Experiments were done at room temperature
(22°C).
N-methyl-D-aspartate (NMDA) receptor blockade, non-
NMDA receptor blockade, and Na+ channel blockade
were all explored. The competitive NMDA antagonist,
amino-phosphonoheptanoic acid (APH, 200 M) was used
because it has been widely studied in the pharmacologic
literature. Noncompetitive NMDA antagonism was studied
using 15 M MK-801. Non-NMDA antagonism was stud-
ied as well, using two 2-amino-3-(3-hydroxy-5-meth-
ylisoxazol-4-yl)propionic acid (AMPA) receptor blockers: the
relatively hydrophilic 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX) at a concentration of 150 M and the relatively
lipophilic 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo[f]quin-
oxaline (NBQX) at 150 M. In addition, transmembrane
Na+ channels were blocked with tetraethylammonium
chloride (TEA) at 150 M.
The cortical tissue was then left overnight in formaldehyde
and processed through 40, 70, 95, and 100% ethanol, fol-
lowed by xylene and paraYn. ParaYn sections were then cut
at a thickness of 6–8 m. Sections were Wnally stained with
H&E (a pair/combination of acid and basic dyes), examined,
and photographed for the presence of dark neurons.
To determine whether Wxation could prevent the saline-
induced artifactual swelling, saline and Wxative were
mixed, and this was used to Wx the tissue. The histology
was compared to tissue exposed to saline Wrst and then
Wxed.
We additionally wished to determine the importance of
the blockade of receptors prior to Wxation. Hence, for one
compound, CNQX, we mixed antagonist and Wxative, and
the resulting mixture was used to Wx the tissue. Subsequent
examination for dark neurons was carried out against the
control tissue that was exposed to CNQX prior to Wxation.
Lastly, the ultrastructural appearance of dark neurons
was compared to that in previous reports. Tissue was post-
Wxed in 1% glutaraldeyhde, stained with uranyl acetate and
lead citrate, embedded in epon, and examined on a Hitachi
M600 electron microscope.
Results
Phosphate-buVered saline treatment alone yielded marked
swelling of neuronal cytoplasm with relative preservation
of a shrunken, pyknotic nucleus that was displaced to one
side by watery cytoplasm (Fig. 1a). Admixture of saline
with formaldehyde (concurrent Wxation) yielded no dark
neurons (Fig. 1b).
Immersion Wxation of excised cortical biopsies yielded
abundant dark neurons, with a tendency to occur at the edge
of the specimen (Fig. 2), representing either delayed form-
aldehyde penetration of the center of the biopsy or death of
cells in the center of the biopsy over the 3 h period preclud-
ing dark neuron formation.
Tissue exposed prior to Wxation to the noncompetitive
NMDA antagonist, MK-801, abolished dark neurons. Very
few shrunken neuronal forms were visible (Fig. 3).
CNQX pretreatment prevented dark neurons (Fig. 4a),
but concurrent Wxation using formaldehyde mixed with123
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Scattered, irregular, small islands of dark neurons could be
found (Fig. 4b).
Pretreatment with the competitive NMDA antagonist,
APH, did not prevent dark neuron formation in biopsies
excised from the cortex (Fig. 5). APH seemed to cause
softer tissue than in the other groups, judged by the consis-
tency of the tissue when handled with tweezers.
NBQX pretreatment prevented all dark neuron formation
(Fig. 6). Both quinoxalinediones (CNQX and NBQX) led
to some degree of hardening of the tissue consistency.
Pretreatment with the Na+ channel blocker, TEA,
showed no ability to prevent dark neuronal forms (Fig. 7).
Plastic-embedded, toluidine blue-stained sections (Fig. 8)
showed the typical dark and light neurons randomly
adjacent to each other. Electron microscopy (Fig. 8) showed
the preservation of cell membranes, typical of dark neuronal
transformation.
Discussion
Dark neurons occur in clinical and experimental neuropa-
thology where living tissue is Wxed with aldehydes, being
generally absent from autopsy material unless the postmor-
tem period is short. The formation of dark neurons is thus a
biotic reaction that requires living neurons to be Wxed. It is
not simply due to inadequate Wxation [14, 24], since it can
be demonstrated when Wxation is adequate by in situ micro-
wave irradiation of tissue [21].
Trauma is one of the many methods for experimentally
producing dark neurons [23]. Simple trauma was originally
Fig. 1 EVect of phosphate-buVered saline and concurrent formalde-
hyde Wxation with saline. Saline alone led to the well-known watery
swelling of cytoplasm (a), while concurrent Wxation (b) prevented
most of this alteration. Insets show the exploded cells
Fig. 2 Direct formaldehyde Wxation of excised cortical tissue yielded
the well-known “biopsy artifact” with dark neurons seen preferentially
around the rim of the specimen, sparing the inner portion (top center).
Inset shows that most neurons are dark and contracted, and not always
accompanied by corkscrew dendrites
Fig. 3 MK-801 prevented most dark neurons in immersion-Wxed
tissue sections. Very few dark neurons can be seen at the left, below
the inset. Higher magniWcation (inset) shows no dark alteration, despite
the usual Wxation-related artifactual spaces surrounding the neurons123
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mechanism [3, 4], presumably by causing expulsion of
water from the neuron. More modern physical mechanisms
have been proposed [11].
However, the occurrence of dark neurons in well-Wxed
experimental specimens, other than those derived from
paradigms of head trauma, indicate that neither trauma
nor poor perfusion can account for the occurrence of dark
neurons. In perfusion-Wxed CNS tissue free of intravascu-
lar red blood cells, dark neurons have been shown in
ischemia [2, 15, 19], hypoglycemia [1], epilepsy [26, 29],
electrical stimulation [13], exposure to excitatory amino
acids [27], in addition to mechanical brain trauma. We
conclude that neither local nor general brain trauma is a
requirement for the production of dark neurons, despite
the fact that dark neurons can be produced in mechanical
brain injury [9, 12].
Although spreading depression causes no permanent
neuronal injury [22], it does cause gliosis [18], indicating
that spreading depression perturbs the tissue. Dark neuron
formation might be stimulated by spreading depression.
The well-known use of mechanical stimulation to cause
both spreading depression and dark neurons might account
for the association of mechanical trauma with dark neurons
generally in the literature. The phenomenon of spreading
depression was discovered in the 1940s by Leão [20] and
consists of a wave of depolarization of the cerebral cortex
that passes through the cortex in a slow progressive wave of
depolarization, followed later by repolarization. The occur-
rence of spreading depression in cortex may explain not
only the presence of dark neurons in cortex, but also their
less common occurrence in non-cortical regions of the
Fig. 4 EVect of CNQX and concurrent formaldehyde Wxation with
CNQX. PreWxation by CNQX alone prevented dark neuron formation
(a), while concurrent Wxation (b) abolished some but not all dark
neurons. A few are seen here in the lower left, accompanied by the
shrunken, corkscrew dendrites (arrows) typical of dark neurons
Fig. 5 APH did not prevent the formation of dark neurons, which are
shown throughout, and in the inset, where only one non-contracted
normal neuronal form is seen
Fig. 6 Pretreatment with NBQX abolished the formation of dark
neurons completely. Inset shows the non-contracted neurons123
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description of spreading depression.
The requirement for a neuron to be alive but perturbed at
the time of Wxation explains the well-known absence of
dark neurons in autopsy material examined by neuropathol-
ogists. The fact that dark neurons are seen in a wide array
of experimental conditions [10] underscores their nonspeci-
Wcity in relation to any one disease process. Conceptually,
dark neurons are best considered to be perturbed neurons at
the time of Wxation.
Infusion of the selective agonist N-methyl-D-aspartate
into brain tissue can produce dark neurons [8] and this pro-
vided one impetus for our study. Hence, our Wnding of the
prevention of dark neurons by some of the NMDA antago-
nists tested in the present study might be expected, if dark
neurons are indeed caused by depolarization related to tis-
sue glutamate release in injury. Dark neurons were pre-
vented by MK-801, but not the longer, polar molecule
APH, perhaps due to its highly polar structure and poor tis-
sue penetration. In contrast, the lipophilic MK-801 mole-
cule easily penetrates the tissue. We did not use slices of
tissue, but rather cuboidal blocks, to more closely simulate
the neurosurgical biopsy and tissue penetration of antago-
nist molecules may be a factor in explaining our results.
Although dark neurons have been described as baso-
philic, they are in fact amphophilic, and show no speciWc
stain aYnity, being visible with both acidic and basic
stains, as well as silver stains, including Golgi [10]. Physi-
cally, they are best considered merely condensed. This
might be due to ion and water Xuxes caused by neurotrans-
mitter release from cells. A second hypothesis is a role of
intracellular actin in the contraction process creating dark
neurons. This might be worthy of study, since actin is pres-
ent in the cell nucleus as well as cytoplasm. A living cell
may not be the critical requirement for dark neuron trans-
formation, but merely cellular contractile capability. This
could explain their appearance in the early postmortem
period, when some biochemical activity is still possible in
the tissue, despite somatic death having occurred hours ago.
However, the electron microscopic appearance of intact cell
and nuclear membranes [1], does suggest that the cell must
still be reasonably intact (i.e., with intact cell membranes,
and with internal contractile capability intact) to produce
this intriguing cellular transformation.
Dark neurons, while appearing intensely black-stained
under the electron microscope after uranyl acetate or lead
citrate staining and very dark using a panoply of stains
under the optical microscope, are still not dead neurons.
This common error in interpretation of sections is impor-
tant, since, for example, steroids may be thought to kill
nerve cells if dark neurons are interpreted as dead nerve
cells [25]. A recent review has catalogued some of the other
instances of misinterpretation of dark neurons as dead neu-
rons [16], underscoring the importance of the nature of dark
neurons, and their interpretation in toxicological and other
types of experimental neuropathological studies.
The dark neuron may be considered as a neuron at risk
of undergoing subsequent cell death, but since recovery and
volumetric expansion may occur en masse in dark neurons
[1], they are reversibly perturbed cells at the time of
Wxation. The possible Wnal common pathway causing such
Fig. 7 TEA had no capacity to prevent the formation of dark neurons,
which are seen to be present throughout. Higher magniWcation (inset)
shows the typical dendritic accentuation of dark neuron transformation
Fig. 8 Toluidine blue-stained, plastic-embedded sections (inset) show
typical appearance of homogenously dark nucleus and cytoplasm.
Electron microscopy shows the characteristic membrane preservation
of a dark neuron, including a process emanating to the upper left, and
including the nuclear membrane (bar = 5 m)123
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of tissue glutamate or some other excitatory stimulus.
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